Skip to main contentSkip to navigation
Sirius Investors
Anbc, Inc.

Anbc, Inc.

SYUP
OTCHealthcare

Anbc, Inc. (SYUP) Investment Research Dashboard

About Anbc, Inc. (SYUP) stock analysis

Get live SYUP stock price $0.00, comprehensive Anbc, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SYUP stock data and investment insights.

0.00
0.00%Today
Market Cap
15.92K
Volume
100.80K
52W High
0.01
52W Low
0.00

Loading chart data...

Anbc, Inc. (SYUP) Overview

Anbc, Inc. (SYUP) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SYUP trades at $0.00 with a market capitalization of 15.92K . Over the past 52 weeks, SYUP has traded between $0.00 and $0.01 , with the current price positioned at approximately 2% of this range . The stock curre...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 15.92K
  • Current price: $0.00
  • 52-week range: $0.00 - $0.01
  • P/E ratio: 0.64

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Shanghai Yutong Pharma, Inc., a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of ...

Company Information

CEO
Jiang-an Lu
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
0

Contact Information

Address
No 2020 Huqingping Road
Country
CN

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -6.20) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Anbc, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Anbc, Inc.
  • Investors should consider how Anbc, Inc. fits within their overall portfolio allocation

Market Cap

15.92K

Beta

-6.20

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

73/100 ⭐⭐⭐⭐⭐

Overall
+0.6%
NYSE
+0.7%
NASDAQ
+0.4%
Sector1D1W1MP/EScore
Financial Services+1.9%+2.8%+4.0%19.2
98/100⭐⭐⭐⭐⭐
Communication Services+1.5%-0.5%+3.1%22.3
74/100⭐⭐⭐⭐⭐
Healthcare+0.6%+1.2%+1.5%24.0
73/100⭐⭐⭐⭐⭐
Basic Materials+0.9%+1.7%+0.2%25.3
66/100⭐⭐⭐⭐
Consumer Defensive-0.0%+2.0%+0.9%29.8
63/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
50/100⭐⭐⭐
Energy-1.7%-3.3%-3.7%19.2
39/100⭐⭐
Utilities-1.1%-0.0%-4.5%26.8
35/100⭐⭐
Industrials+0.7%+0.5%-9.8%30.0
21/100
Technology+0.9%-1.3%-6.9%40.9
18/100
Consumer Cyclical+0.3%-1.7%-6.0%42.8
14/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.